REVVITY, INC Current Federal Tax Expense (Benefit)
REVVITY, INC (RVTY) reported Current Federal Tax Expense (Benefit) of $12.26 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-02-24
- REVVITY, INC current federal tax expense (benefit) for fiscal 2025 was $12.26M, a 71.30% decline from fiscal 2024.
- REVVITY, INC current federal tax expense (benefit) for fiscal 2024 was $42.71M, a 7.31% increase from fiscal 2023.
- REVVITY, INC current federal tax expense (benefit) for fiscal 2023 was $39.80M, a 65.52% decline from fiscal 2023.
- REVVITY, INC current federal tax expense (benefit) for fiscal 2023 was $115.44M, a 25.48% decline from fiscal 2022.
| Period end | Current Federal Tax Expense (Benefit) 12 month | Current Federal Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-28 | $12.26M 10-K · filed 2026-02-24 | |
| 2024-12-29 | $42.71M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $39.80M 10-K · filed 2026-02-24 | |
| 2023-01-01 | $115.44M 10-K · filed 2025-02-25 | |
| 2022-01-02 | $154.91M 10-K · filed 2024-02-27 | $150.62M 10-K · filed 2022-03-03 |
| 2021-01-03 | $39.88M 10-K · filed 2023-03-01 | $21.26M 10-K · filed 2021-03-02 |
| 2019-12-29 | $3.73M 10-K · filed 2022-03-03 | |
| 2018-12-30 | $7.94M 10-K · filed 2021-03-02 | |
| 2017-12-31 | $62.00M 10-K · filed 2020-02-25 | |
| 2017-01-01 | $14.00K 10-K · filed 2019-02-26 | |
| 2016-01-03 | -$10.95M 10-K · filed 2018-02-27 | -$5.53M 10-K · filed 2016-03-01 |
| 2014-12-28 | -$6.42M 10-K · filed 2017-02-28 | -$262.00K 10-K · filed 2015-02-24 |
| 2013-12-29 | $2.33M 10-K · filed 2016-03-01 | -$1.29M 10-K · filed 2014-02-25 |
| 2012-12-30 | -$3.64M 10-K · filed 2015-02-24 | -$5.23M 10-K · filed 2013-02-26 |
| 2012-01-01 | $18.31M 10-K · filed 2014-02-25 | |
| 2011-01-02 | $6.50M 10-K · filed 2013-02-26 | |
| 2010-01-03 | -$30.99M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |